查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404770

體外受精 (IVF) 市場規模、佔有率和趨勢分析報告：按設備、程序類型、最終用途、地區和細分市場預測，2024-2030 年

In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media), By Procedure Type (Fresh Nondonor, Frozen Nondonor), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

體外受精 (IVF) 市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球體外受精（IVF）市場規模將達到374億美元，2024年至2030年複合年成長率為5.54%。

市場成長歸功於市場參與者的持續努力、生活方式改變導致不孕症發生率的增加以及政府改善報銷政策的舉措。不孕症治療方式的擴展，例如用於不孕症治療方法的卵細胞質內單一精蟲顯微注射術（ICSI）預計將對市場成長產生正面影響。

可以防止體外受精（IVF）期間遺傳異常轉移的基因組測試設施的可用性預計將推動 IVF 市場的發展。由於體外受精（IVF）治療數量的增加，保險公司正在為體外受精（IVF）治療提供保險。例如，2023 年 5 月，太平洋藍十字推出了增強型個人健康保險，這是一項健康和牙科計劃，其中包含計劃生育福利，包括生育藥物、不孕症治療和收養的保險。透過這項增強，太平洋藍十字成為加拿大第一家也是唯一一家提供計劃生育福利作為個人健康和牙科計劃一部分的保險公司。這使我們能夠設定與競爭對手相比競爭的價格，並降低體外受精 (IVF) 療程的成本。隨著治療變得越來越自動化和標準化，體外受精 (IVF) 正在推動市場發展。

總合生育率（TFR）下降是由於社會行為轉變等因素所造成的。這些因素包括從農村社會轉變為城市社會的轉變、首次懷孕年齡的增加、延遲結婚、就業增加和結婚率下降。 2020 年 3 月，美國生殖醫學會和加拿大生育與男科學會宣布，由於 COVID-19 ，美國和加拿大暫停了現場生育治療。然而，由於放鬆了 COVID-19 限制，許多國家已恢復治療。 2022 年 1 月在《婦產科》雜誌上發表的一項研究報告稱，COVID-19 疫苗不會損害體外受精 (IVF) 的結果。預計這將證明疫苗接種者對體外受精（IVF）的普及。

體外受精 (IVF) 市場報告亮點：

  • 以手術類型來看，與其他手術相比，使用冷凍非捐贈程序進行體外受精(IVF) 的週期數不斷增加，因此，到2023 年，使用冷凍非捐贈程序進行體外受精(IVF) 的需求將會增加。,使用冷凍非供體程序的體外受精（IVF）佔據了市場主導地位。
  • 從最終用途來看，市場成長的推動因素包括對 ART 治療的需求不斷增加、成本效益、專家的可用性、與卵子和精子庫的良好關係以及醫院感染的可能性極小或沒有。不孕不育治療診所市場主導了市場2023年，由於其驅動力。
  • 按設備分類，2023年培養液細分市場佔據最大的銷售佔有率。這是由於為提高培養基效率而進行的研究活動越來越多，以及政府對卵子和精子冷凍工作者的資助和機構支持不斷增加。
  • 由於診所擴大採用延時顯微鏡等先進技術、負擔得起的治療以及遵守醫療標準，歐洲將在 2023 年佔據最大的市場佔有率。
  • 由於對不孕症治療的高需求以及支持 IVF 的政策和舉措的實施，預計亞太地區對體外受精 (IVF) 的需求將會增加。在日本，符合資格的夫婦最多可以申請三個週期的自籌資金，每個週期 1,920 美元。
  • 亞太地區的新興國家正在致力於法律改革，以促進該地區接受治療。例如，2020年2月，印度政府核准了一項法案，對提供輔助生殖技術服務的診所進行監管，包括體外受精（IVF）、人工授精和代理孕母。
  • 2021年6月，法國下議院正式通過一項法律，允許單身女性和女同性戀夫婦獲得輔助生殖技術。這項具有里程碑意義的立法標誌著一個重要的里程碑，為這些個人和夫婦提供免費的不孕症治療，包括體外受精 (IVF)。
  • 2023年6月，印度第二大生育連鎖企業Nova IVF Fertility宣布，計劃在未來四年內透過有機擴張和收購，將中心數量擴大到100家。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
  • 市場區隔
  • 從使用者觀點分析
    • 消費行為分析
    • 市場影響力分析
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTLE分析
    • 定性分析：COVID-19 疾病對體外受精 (IVF) 市場的影響

第4章體外受精 (IVF) 市場：治療類型分析

  • 2023 年和 2030 年體外受精 (IVF)市場佔有率按手術類型分析
  • 細分儀表板
  • 2018年至2030年治療類型的市場規模、預測與趨勢分析
    • 新鮮的非捐贈者
    • 冷凍非捐贈者
    • 新的捐贈者
    • 冷凍供體

第5章體外受精 (IVF) 市場：最終用途分析

  • 2023 年及 2030 年體外受精 (IVF) 最終用途市場佔有率分析
  • 細分儀表板
  • 2018-2030 年最終用途市場規模、預測與趨勢分析
    • 不孕不育診所
    • 醫院及其他環境

第6章體外受精（IVF）市場：設備分析

  • 2023年及2030年體外受精（IVF）市場佔有率分析
  • 細分儀表板
  • 全球體外受精 (IVF) 市場（按設備），2023-2030 年
  • 2018年至2030年設備市場規模、預測、趨勢分析
    • 培養基
    • 免洗裝置
    • 資本設備

第7章 區域展望

  • 按地區分類的體外受精 (IVF) 市場：主要市場亮點
  • 生育診所列表
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章競爭分析

  • 公司簡介
    • OvaScience, Inc.
    • Vitrolife AB（publ）
    • Emd Serono, Inc.
    • FUJIFILM Irvine Scientific
    • The Cooper Companies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bayer AG
    • Merck &Co., Inc.
    • Cook Medical LLC（Cook Group）
    • Genea Biomedx
    • Progyny, Inc.
    • Boston IVF
    • Ferring Pharmaceutical BV
  • 公司分類
  • 公司市場分析
  • 策略規劃

第 9 章建議/主要市場見解

Product Code: 978-1-68038-823-7

In Vitro Fertilization Market Growth & Trends:

The global in vitro fertilization market size is expected to reach USD 37.4 billion by 2030, with a CAGR of 5.54% from 2024 to 2030, based on a new report by Grand View Research, Inc.The market's growth can be attributed to the continuous efforts of the market players, an increase in the incidence of infertility due to lifestyle changes, and government initiatives to improve reimbursement policies. Expansion of fertility procedures, such as Intracytoplasmic sperm injection (ICSI) for treating infertility, is expected to have a positive impact on market growth.

The availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during in vitro fertilization (IVF) is expected to drive the IVF market. The insurance providers are providing coverage for IVF procedures owing to an increase in the number of IVF treatments. For instance, in May 2023, Pacific Blue Cross introduced an enhanced Personal Health Insurance, a health & dental plan, which incorporates family planning benefits, including coverage for fertility drugs, fertility treatments, and adoption. With this enhancement, Pacific Blue Cross became the first and only provider in Canada to offer family planning benefits as part of an individual health & dental plan. This led to competitive pricing and moderated IVF treatment costs. This procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.

A decline in the Total Fertility Rate (TFR) results from factors, such as behavioral shifts in society. These factors include a shift from rural to urban societies, increased age of the first pregnancy, postponement of marriage, increased employment, and lower marriage rates. In March 2020, in-person fertility treatments in the U.S. and Canada were suspended due to COVID-19 by the American Society of Reproductive Medicine and Canadian Fertility and Andrology Society. However, treatment is resumed in many countries with the ease of COVID-19 restrictions. The research findings published by the Obstetrics & Gynecology journal in January 2022 reported that COVID-19 vaccines wouldn't harm IVF outcomes. This is expected to prove the uptake of IVF in eligible vaccinated individuals.

In Vitro Fertilization Market Report Highlights:

  • Based on procedure type, the frozen nondonor type segment dominated the market in 2023 owing to the growing demand for the number of IVF cycles with the aid of frozen nondonor procedures increasing as compared to other procedures
  • Based on end-use, the fertility clinics segment dominated the market in 2023 owing to the rise in demand for ART treatments along with cost-effectiveness, availability of specialists, good relations with the egg & sperm banks, and minimal or no chances of hospital-acquired infections to drive the growth of the market
  • Based on instrument, the culture media segment held the largest revenue share in 2023 owing to a rise in the number of research activities being undertaken to improve the efficiency of culture media along with an increase in government funding and organizational support for employees for egg/sperm freezing
  • Europe held the largest market share in 2023 due to the growing adoption of advanced technologies, such as time-lapse microscopy by the clinics, availability of affordable treatment, and adherence to medical standards
  • Asia Pacific is expected to witness increased demand for IVF owing to high demand for fertility treatments and implemented policies & initiatives to support IVF. In Japan, eligible couples can apply for co-funding for a maximum of three cycles with USD 1,920 for each cycle
  • The developing countries in the Asia Pacific are undertaking legal reforms to promote treatment adoption in the region. For instance, in February 2020, the Government of India approved a bill to regulate clinics offering reproduction assistance services, including IVF, artificial insemination, and surrogacy
  • In June 2021, the lower house of parliament in France officially passed a law granting single women and lesbian couples access to medically assisted reproduction. This groundbreaking law marks a significant milestone, allowing these individuals and couples to receive fertility treatments, including IVF, at no cost
  • In June 2023, Nova IVF Fertility, India's second-largest infertility treatment chain, announced that they plan to reach 100 centers in the next four years through organic expansion and acquisitions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Procedure Type
    • 1.1.2. End-use
    • 1.1.3. Instrument
    • 1.1.4. Region
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
    • 1.3.1. Information procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
    • 1.3.6. Details of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Volume Price Analysis
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Research Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Procedure Type
    • 2.2.2. End-use
    • 2.2.3. Instrument
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Segmentation
  • 3.3. User Perspective Analysis
    • 3.3.1. Consumer Behavior Analysis
    • 3.3.2. Market Influencer Analysis
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTLE Analysis
    • 3.5.3. Qualitative Analysis: Impact of COVID-19 on IVF Market

Chapter 4. In Vitro Fertilization Market: Procedure Type Analysis

  • 4.1. In Vitro Fertilization by Procedure Type Market Share Analysis, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global In Vitro Fertilization Procedures Market, by Type, 2018 - 2030
  • 4.4. Market Size and Forecasts and Trend Analysis, 2018 - 2030 for the Procedure Type
    • 4.4.1. Fresh Nondonor
      • 4.4.1.1. Fresh nondonor market, 2018 - 2030 (USD Million)
    • 4.4.2. Frozen Nondonor
      • 4.4.2.1. Frozen nondonor market, 2018 - 2030 (USD Million)
    • 4.4.3. Fresh Donor
      • 4.4.3.1. Fresh donor market, 2018 - 2030 (USD Million)
    • 4.4.4. Frozen Donor
      • 4.4.4.1. Frozen donor market, 2018 - 2030 (USD Million)

Chapter 5. In Vitro Fertilization Market: End-use Analysis

  • 5.1. In Vitro Fertilization End-use Market Share Analysis, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Market Size and Forecasts and Trend Analysis, 2018 - 2030 for the following End-use
    • 5.3.1. Fertility Clinics
      • 5.3.1.1. Fertility clinics market, 2018 - 2030 (USD Million)
    • 5.3.2. Hospitals and Other Settings
      • 5.3.2.1. Hospitals and other settings market, 2018 - 2030 (USD Million)

Chapter 6. In Vitro Fertilization Market: Instrument Analysis

  • 6.1. In Vitro Fertilization (IVF) Market Share Analysis, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global IVF Market, by Instrument, 2023 to 2030
  • 6.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the Instrument
    • 6.4.1. Culture Media
      • 6.4.1.1. Culture media market, 2018 - 2030 (USD Million)
    • 6.4.2. Disposable Devices
      • 6.4.2.1. Disposable devices market, 2018 - 2030 (USD Million)
    • 6.4.3. Capital Equipment
      • 6.4.3.1. Capital equipment market, 2018 - 2030 (USD Million)

Chapter 7. Regional Outlook

  • 7.1. IVF Market by Region: Key Marketplace Takeaway
  • 7.2. List of Few Fertility Clinics
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. MEA
  • 7.3. North America
    • 7.3.1. North America IVF market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. U.S. estimated fertility rate, 2018 - 2030 (%)
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Reimbursement scenario
      • 7.3.2.4. U.S. IVF market, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Canada estimated fertility rate, 2018 - 2030 (%)
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Reimbursement scenario
      • 7.3.3.4. Canada IVF market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe IVF market, 2018 - 2030 (USD Million)
    • 7.4.2. France
      • 7.4.2.1. France estimated fertility rate, 2018 - 2030 (%)
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Reimbursement scenario
      • 7.4.2.4. France IVF market, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Germany estimated fertility rate, 2018 - 2030 (%)
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Reimbursement Scenario
      • 7.4.3.4. Germany IVF market, 2018 - 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Italy estimated fertility rate, 2018 - 2030 (%)
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Reimbursement scenario
      • 7.4.4.4. Italy IVF market, 2018 - 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Spain estimated fertility rate, 2018 - 2030 (%)
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Reimbursement scenario
      • 7.4.5.4. Spain IVF market, 2018 - 2030 (USD Million)
    • 7.4.6. UK
      • 7.4.6.1. UK estimated fertility rate, 2018 - 2030 (%)
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Reimbursement scenario
      • 7.4.6.4. UK IVF market, 2018 - 2030 (USD Million)
    • 7.4.7. Belgium
      • 7.4.7.1. Belgium estimated fertility rate, 2018 - 2030 (%)
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Reimbursement scenario
      • 7.4.7.4. Belgium IVF market, 2018 - 2030 (USD Million)
    • 7.4.8. Netherlands
      • 7.4.8.1. Netherlands estimated fertility rate, 2018 - 2030 (%)
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Reimbursement scenario
      • 7.4.8.4. Netherlands IVF market, 2018 - 2030 (USD Million)
    • 7.4.9. Switzerland
      • 7.4.9.1. Switzerland estimated fertility rate, 2018 - 2030 (%)
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Reimbursement scenario
      • 7.4.9.4. Switzerland IVF market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific IVF market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Japan estimated fertility rate, 2018 - 2030 (%)
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Rembursement scenario
      • 7.5.2.4. Japan IVF market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. China estimated fertility rate, 2018 - 2030 (%)
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Reimbursement scenario
      • 7.5.3.4. China IVF market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. India estimated fertility rate, 2018 - 2030 (%)
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Reimbursement scenario
      • 7.5.4.4. India IVF market, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Australia estimated fertility rate, 2018 - 2030 (%)
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Reimbursement scenario
      • 7.5.5.4. Australia IVF market, 2018 - 2030 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. South Korea estimated fertility rate, 2018 - 2030 (%)
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Reimbursement scenario
      • 7.5.6.4. South Korea IVF market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America IVF market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Brazil estimated fertility rate, 2018 - 2030 (%)
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Reimbursement scenario
      • 7.6.2.4. Brazil IVF market, 2018 - 2030 (USD Million)
    • 7.6.3. Mexico
      • 7.6.3.1. Mexico estimated fertility rate, 2018 - 2030 (%)
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Reimbursement scenario
      • 7.6.3.4. Mexico IVF market, 2018 - 2030 (USD Million)
    • 7.6.4. Argentina
      • 7.6.4.1. Argentina estimated fertility rate, 2018 - 2030 (%)
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Reimbursement scenario
      • 7.6.4.4. Argentina IVF market, 2018 - 2030 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. MEA IVF market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. South Africa estimated fertility rate, 2018 - 2030 (%)
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Reimbursement scenario
      • 7.7.2.4. South Africa IVF market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Saudi Arabia estimated fertility rate, 2018 - 2030 (%)
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Reimbursement scenario
      • 7.7.3.4. Saudi Arabia IVF market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. UAE estimated fertility rate, 2018 - 2030 (%)
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Reimbursement scenario
      • 7.7.4.4. UAE IVF market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Analysis

  • 8.1. Company Profiles
    • 8.1.1. OvaScience, Inc.
      • 8.1.1.1. Overview
      • 8.1.1.2. Financial Performance
      • 8.1.1.3. Service Benchmarking
      • 8.1.1.4. Strategic Initiatives
    • 8.1.2. Vitrolife AB (publ)
      • 8.1.2.1. Overview
      • 8.1.2.2. Financial Performance
      • 8.1.2.3. Service Benchmarking
      • 8.1.2.4. Strategic Initiatives
    • 8.1.3. Emd Serono, Inc.
      • 8.1.3.1. Overview
      • 8.1.3.2. Financial Performance
      • 8.1.3.3. Service Benchmarking
      • 8.1.3.4. Strategic Initiatives
    • 8.1.4. FUJIFILM Irvine Scientific
      • 8.1.4.1. Overview
      • 8.1.4.2. Financial Performance
      • 8.1.4.3. Service Benchmarking
      • 8.1.4.4. Strategic Initiatives
    • 8.1.5. The Cooper Companies, Inc.
      • 8.1.5.1. Overview
      • 8.1.5.2. Financial Performance
      • 8.1.5.3. Service Benchmarking
      • 8.1.5.4. Strategic Initiatives
    • 8.1.6. Thermo Fisher Scientific, Inc.
      • 8.1.6.1. Overview
      • 8.1.6.2. Financial Performance
      • 8.1.6.3. Service Benchmarking
      • 8.1.6.4. Strategic Initiatives
    • 8.1.7. Bayer AG
      • 8.1.7.1. Overview
      • 8.1.7.2. Financial Performance
      • 8.1.7.3. Service Benchmarking
      • 8.1.7.4. Strategic Initiatives
    • 8.1.8. Merck & Co., Inc.
      • 8.1.8.1. Overview
      • 8.1.8.2. Financial Performance
      • 8.1.8.3. Service Benchmarking
      • 8.1.8.4. Strategic Initiatives
    • 8.1.9. Cook Medical LLC (Cook Group)
      • 8.1.9.1. Overview
      • 8.1.9.2. Financial Performance
      • 8.1.9.3. Service Benchmarking
      • 8.1.9.4. Strategic Initiatives
    • 8.1.10. Genea Biomedx
      • 8.1.10.1. Overview
      • 8.1.10.2. Financial Performance
      • 8.1.10.3. Service Benchmarking
      • 8.1.10.4. Strategic Initiatives
    • 8.1.11. Progyny, Inc.
      • 8.1.11.1. Overview
      • 8.1.11.2. Financial Performance
      • 8.1.11.3. Service Benchmarking
      • 8.1.11.4. Strategic Initiatives
    • 8.1.12. Boston IVF
      • 8.1.12.1. Overview
      • 8.1.12.2. Financial Performance
      • 8.1.12.3. Service Benchmarking
      • 8.1.12.4. Strategic Initiatives
    • 8.1.13. Ferring Pharmaceutical B.V.
      • 8.1.13.1. Overview
      • 8.1.13.2. Financial Performance
      • 8.1.13.3. Service Benchmarking
      • 8.1.13.4. Strategic Initiatives
  • 8.2. Company Categorization
  • 8.3. Company Market Position Analysis
  • 8.4. Strategy Mapping

Chapter 9. Recommendations/Key Market Insights

List of Tables

  • Table 1. List Of Secondary Sources
  • Table 2. List Of Abbreviations
  • Table 3. Clinical Trial Analysis
  • Table 4. Comparison Between the Fresh and Frozen Donor Treatment (U.S.)
  • Table 5. Canadian Law On ART
  • Table 6. Status Of Public Funding for IVF in Canada
  • Table 7. Global In-Vitro Fertilization Market, by Region, 2018 - 2030 (USD Million)
  • Table 8. Global In-Vitro Fertilization Market, by Type, 2018 - 2030 (USD Million)
  • Table 9. Global In-Vitro Fertilization Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 10. Global In-Vitro Fertilization Instruments Market, by Region, 2018 - 2030 (USD Million)
  • Table 11. Global In-Vitro Fertilization Instruments Market, by Type, 2018 - 2030 (USD Million)
  • Table 12. North America In Vitro Fertilization, by Country, 2018 - 2030 (USD Million)
  • Table 13. North America In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 14. North America In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 15. North America In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 16. North America In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 17. U.S. In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 18. U.S. In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 19. U.S. In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 20. Canada In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 21. Canada In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 22. Canada In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 23. Europe In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 24. Europe In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 25. Europe In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 26. Europe In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 27. Europe In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 28. France In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 29. France In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30. France In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 31. Germany In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 32. Germany In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 33. Germany In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 34. Italy In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 35. Italy In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 36. Italy In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 37. Spain In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 38. Spain In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 39. Spain In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 40. UK In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 41. UK In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 42. UK In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 43. Belgium In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 44. Belgium In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45. Belgium In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 46. Netherlands In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 47. Netherlands In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 48. Netherlands In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 49. Switzerland In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 50. Switzerland In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 51. Switzerland In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 52. Asia Pacific In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 53. Asia Pacific In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 54. Asia Pacific In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 55. Asia Pacific In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 56. Asia Pacific In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 57. Japan In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 58. Japan In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 59. Japan In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 60. China In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 61. China In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 62. China In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 63. India In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 64. India In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 65. India In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 66. Australia In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 67. Australia In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 68. Australia In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 69. South Korea In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 70. South Korea In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 71. South Korea In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 72. Latin America In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 73. Latin America In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 74. Latin America In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 75. Latin America In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 76. Latin America In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 77. Brazil In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 78. Brazil In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 79. Brazil In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 80. Mexico In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 81. Mexico In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 82. Mexico In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 83. Argentina In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 84. Argentina In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 85. Argentina In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 86. MEA In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 87. MEA In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 88. MEA In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 89. MEA In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 90. MEA In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 91. South Africa In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 92. South Africa In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 93. South Africa In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 94. Saudi Arabia In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 95. Saudi Arabia In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 96. Saudi Arabia In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 97. UAE In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 98. UAE In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 99. UAE In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 In vitro fertilization market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Supply-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment outlook
  • Fig. 11 Segment outlook
  • Fig. 12 Competitive scenario
  • Fig. 13 In Vitro Fertilization (IVF) parent market outlook
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Market dynamics
  • Fig. 16 Market driver relevance analysis (Current & future impact)
  • Fig. 17 Market restraint relevance analysis (Current & future impact)
  • Fig. 18 In vitro fertilization (IVF) market: Porter's five forces analysis
  • Fig. 19 In vitro fertilization (IVF) market: PESTLE analysis
  • Fig. 20 IVF type market: Segment dashboard
  • Fig. 21 IVF market by type: Market share analysis, 2023 & 2030
  • Fig. 22 Global In Vitro Fertilization (IVF) procedures market, by type, 2018 - 2030 (USD Million)
  • Fig. 23 Fresh nondonor market, 2018 - 2030 (USD Million)
  • Fig. 24 Frozen nondonor market 2018 - 2030 (USD Million)
  • Fig. 25 Fresh donor market 2018 - 2030 (USD Million)
  • Fig. 26 Frozen donor market 2018 - 2030 (USD Million)
  • Fig. 27 IVF End-Use market: Segment dashboard
  • Fig. 28 IVF market by End-Use: Market share analysis, 2023 & 2030
  • Fig. 29 Fertility clinics market, 2018 - 2030 (USD Million)
  • Fig. 30 Hospitals and other settings market 2018 - 2030 (USD Million)
  • Fig. 31 IVF instrument market: Segment dashboard
  • Fig. 32 IVF market by instrument: Market share analysis, 2023 & 2030
  • Fig. 33 Global In Vitro Fertilization (IVF) procedures market, by instrument, 2018 - 2030 (USD Million)
  • Fig. 34 Culture media market, 2018 - 2030 (USD Million)
  • Fig. 35 Disposable devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Capital equipment market, 2018 - 2030 (USD Million)
  • Fig. 37 IVF market revenue, by region
  • Fig. 38 Regional key marketplace takeaway
  • Fig. 39 Regional key marketplace takeaway
  • Fig. 40 North America IVF market, 2018 - 2030 (USD Million)
  • Fig. 41 North America IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. estimated fertility rate, 2018 - 2030 (%)
  • Fig. 43 U.S. IVF market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada estimated fertility rate, 2018 - 2030 (%)
  • Fig. 46 Canada IVF market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe IVF market, 2018 - 2030 (USD Million)
  • Fig. 49 Europe IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 50 France estimated fertility rate, 2018 - 2030 (%)
  • Fig. 51 France IVF market, 2018 - 2030 (USD Million)
  • Fig. 52 France IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 53 Germany estimated fertility rate, 2018 - 2030 (%)
  • Fig. 54 Germany IVF market, 2018 - 2030 (USD Million)
  • Fig. 55 Germany IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 56 Italy estimated fertility rate, 2018 - 2030 (%)
  • Fig. 57 Italy IVF market, 2018 - 2030 (USD Million)
  • Fig. 58 Italy IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 59 Spain estimated fertility rate, 2018 - 2030 (%)
  • Fig. 60 Spain IVF market, 2018 - 2030 (USD Million)
  • Fig. 61 Spain IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 62 UK estimated fertility rate, 2018 - 2030 (%)
  • Fig. 63 UK IVF market, 2018 - 2030 (USD Million)
  • Fig. 64 UK IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 65 Belgium estimated fertility rate, 2018 - 2030 (%)
  • Fig. 66 Belgium IVF market, 2018 - 2030 (USD Million)
  • Fig. 67 Belgium IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 68 Netherlands estimated fertility rate, 2018 - 2030 (%)
  • Fig. 69 Netherlands IVF market, 2018 - 2030 (USD Million)
  • Fig. 70 Netherlands IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 71 Switzerland estimated fertility rate, 2018 - 2030 (%)
  • Fig. 72 Switzerland IVF market, 2018 - 2030 (USD Million)
  • Fig. 73 Switzerland IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific IVF market, 2018 - 2030 (USD Million)
  • Fig. 75 Asia Pacific IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 76 Japan estimated fertility rate, 2018 - 2030 (%)
  • Fig. 77 Japan IVF market, 2018 - 2030 (USD Million)
  • Fig. 78 Japan IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 79 China estimated fertility rate, 2018 - 2030 (%)
  • Fig. 80 China IVF market, 2018 - 2030 (USD Million)
  • Fig. 81 China IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 82 India. estimated fertility rate, 2018 - 2030 (%)
  • Fig. 83 India IVF market, 2018 - 2030 (USD Million)
  • Fig. 84 India IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 85 Australia estimated fertility rate, 2018 - 2030 (%)
  • Fig. 86 Australia IVF market, 2018 - 2030 (USD Million)
  • Fig. 87 Australia IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 88 South Korea estimated fertility rate, 2018 - 2030 (%)
  • Fig. 89 South Korea IVF market, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 91 Latin America IVF market, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 93 Brazil estimated fertility rate, 2018 - 2030 (%)
  • Fig. 94 Brazil IVF market, 2018 - 2030 (USD Million)
  • Fig. 95 Brazil IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 96 Mexico estimated fertility rate, 2018 - 2030 (%)
  • Fig. 97 Mexico IVF market, 2018 - 2030 (USD Million)
  • Fig. 98 Mexico IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 99 Argentina estimated fertility rate, 2018 - 2030 (%)
  • Fig. 100 Argentina IVF market, 2018 - 2030 (USD Million)
  • Fig. 101 Argentina IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 102 MEA IVF market, 2018 - 2030 (USD Million)
  • Fig. 103 MEA IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 104 South Africa estimated fertility rate, 2018 - 2030 (%)
  • Fig. 105 South Africa IVF market, 2018 - 2030 (USD Million)
  • Fig. 106 South Africa IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 107 Saudi Arabia estimated fertility rate, 2018 - 2030 (%)
  • Fig. 108 Saudi Arabia IVF market, 2018 - 2030 (USD Million)
  • Fig. 109 Saudi Arabia IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 110 UAE estimated fertility rate, 2018 - 2030 (%)
  • Fig. 111 UAE IVF market, 2018 - 2030 (USD Million)
  • Fig. 112 UAE IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 113 Company categorization
  • Fig. 114 Company market position analysis
  • Fig. 115 Strategy mapping